Cadogan, Kianna
Shaffer, Seth R.
Singer, Alexander
Reimer, Aleisha
Knox, Natalie
Rumore, Jillian
Christianson, Sara
Alexander, David C.
Forbes, Jessica D.
Bernstein, Charles N.
Article History
Received: 15 January 2024
Accepted: 11 June 2024
First Online: 17 June 2024
Declarations
:
: Ethics approval was not required for this study. Participation in the survey was voluntary and informed consent was obtained from all participants.
: Not applicable.
: CB is supported by the Bingham Chair in Gastroenterology. CB has served on advisory Boards for AbbVie Canada, Amgen Canada, Bristol Myers Squibb Canada, Roche Canada, Janssen Canada, Sandoz Canada, Takeda Canada, and Pfizer Canada; Consultant for Mylan Pharmaceuticals and Takeda; Educational grants from Abbvie Canada, Pfizer Canada, Takeda Canada, and Janssen Canada. Speaker’s panel for Abbvie Canada, Janssen Canada, Medtronic Canada, and Takeda Canada. Received research funding from Abbvie Canada and Pfizer Canada. SS has served on advisory boards or consulted to Takeda Canada, Janssen Canada, and Pfizer Canada. SS has served on advisory boards, and consulted to Janssen Canada, Takeda Canada, Abbvie Canada, and Pfizer Canada. AS has accepted honoraria from the Canadian Cardiovascular Society and the Manitoba Southern Chiefs Organization for advisory services. AS has conducted research funded by IBM and Calian. All other authors have nothing to declare.